The $2 Trillion Valuation Debate Skips What Anthropic Knows 
Pharmacore secures funding to improve medication regimen reviews in long-term care Foresite Capital Strengthens Investor Relations and Business Development Teams with Addition of Hadi Tabbaa as Managing Director
Tabbaa most recently served as the global head of investor relations at B Capital and…
Tonix Pharmaceuticals Announces Pricing of $4.5 Million Public Offering
CHATHAM, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix”…
ALUULA Announces Third Quarter 2023 Results and Management Change
Victoria, British Columbia–(Newsfile Corp. – September 28, 2023) – ALUULA Composites Inc. (TSXV: AUUA) (the…
Commercial Bank of Dubai Co-Hosts Future Sustainability Forum for a Greener Tomorrow
DUBAI, Sept 29, 2023 – (ACN Newswire) – As the UAE prepares to host the…
IonQ Announces New $25.5M Quantum Deal with United States Air Force Research Lab
Deal solidifies public-private relationship advancing quantum science and U.S. national security interests COLLEGE PARK, Md.–(BUSINESS…
Elevate Security Named to the 3rd Annual Intelligent Applications Top 40 List
IA40 Summit in Seattle October 10th& 11th Celebrates the 2023 Winners Innovating with AI and…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of VNET Group, Inc. (VNET) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Scynexis, Inc. (SCYX) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein’s Labs
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the…
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein’s Labs
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the…
Medicenna Announces Results of Annual and Special Meeting of Shareholders
TORONTO and HOUSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”)…
Medicenna Announces Results of Annual and Special Meeting of Shareholders
TORONTO and HOUSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”)…
TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update
Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC…
Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update
Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC…
NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer
Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for…
NANOBIOTIX Announces Presentation of First Data From Phase 1 Study Evaluating NBTXR3 for Patients With Locally Advanced Pancreatic Cancer
Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for…
Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day
Presented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including…
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,”…